sst2 agonists (GSK)

N/A

Report date: 2025/03/20 09:45:16
NME

Base Information

Drug Namesst2 agonists (GSK)
Drug Alias Namesomatostatin 2 receptor agonists (GSK)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 2 agonists
TargetsSomatostatin receptor 2
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A